NEW YORK, Dec. 2 (GenomeWeb News) - Locus Pharmaceuticals will use supercomputing power from IBM's Deep Computing Capacity on Demand center to support its drug discovery and development activities, IBM said today.

Locus will augment its existing 2.3 teraflop supercomputing infrastructure by tapping into an IBM eServer Linux cluster system located at IBM's on-demand center in Poughkeepsie, New York.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.